Hogan Lovells advised OncoVerity on the deal. OncoVerity, a pioneer in applying advanced bioinformatics to drug development, announced the closing of a Series A extension financing...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here